title: Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era.
authors.affiliation: MD Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; and University of Ottawa, Ottawa, Canada.
authors.forename: Nitin
authors.initials: N
authors.lastname: Jain
authors.affiliation: MD Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; and University of Ottawa, Ottawa, Canada.
authors.forename: David
authors.initials: D
authors.lastname: Steensma
authors.affiliation: MD Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; and University of Ottawa, Ottawa, Canada.
authors.forename: David J
authors.initials: DJ
authors.lastname: Stewart
authors.affiliation: MD Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; and University of Ottawa, Ottawa, Canada hkantarjian@mdanderson.org.
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D019458:Insurance Coverage; D007348:Insurance, Health; D058991:Patient Protection and Affordable Care Act; D018579:Patient Selection